TNXP analyst estimates
Tonix Pharmaceuticals (TNXP) analyst ratings, the average price target and its range, and every firm's latest call.
TNXP analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Oct 26, 2026 | Canaccord Genuity | Tonix Pharmaceuticals initiated with a Buy at Canaccord | $18.00 |
| Aug 10, 2026 | Raymond James | Tonix Pharmaceuticals price target raised to $27 from $25 at Raymond James | $27.00 |
| Jun 24, 2026 | Raymond James | Tonix Pharmaceuticals initiated with a Strong Buy at Raymond James | $26.00 |
- 0 firms rate TNXP: 0 buy, 0 hold, 0 sell.
- The average price target is $22.50 from None analysts, from $18.00 to $27.00.
Updated 2026-11-12 15:54 UTC